Education
About Us
Working with TipRanks
Follow Us
Liquidia Technologies Inc (LQDA)
NASDAQ:LQDA
LQDA Analyst Ratings
Moderate Buy
9 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LQDA Stock 12 Month Forecast
Average Price Target
$35.64
▲(36.60% Upside)
| Highest Price Target$54.00 | Average Price Target$35.64 | Lowest Price Target$6.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
$43
Buy
64.81%
Upside
Initiated
08/15/25
Promising Growth and Market Differentiation for Liquidia Technologies: Buy Rating with $43 Price TargetSetup - Assume at Buy, PT $43: *Slides Attached* There are 2 overhangs to LQDA's stock - UTHR patent litigation & INSM's QD TPIP. But at $2.2B mkt cap, we see upside 1) We expect Yutrepia to beat FY'25 (we est. $108M vs $48M cons) & co hits profitability Q4'25, 2) highly unlikely Yutrepia is pulled off mkt from litigation ('327 decision Sep/Aug), 3) oppty for next-gen BID L606 to differentiate vs TPIP (OL data at R&D Day this fall). We model PS $880M for Yutrepia & $491M for L606 (55% POS). Buy, PT $43. ** For our full report, please see the attached ~90-slide deck ** We're assuming coverage of Liquidia Corporation (LQDA) with a Buy rating and PT of $43.
BTIG
$40→$49
Buy
87.81%
Upside
Reiterated
08/13/25
H.C. Wainwright
$35
Buy
34.15%
Upside
Reiterated
08/13/25
Strong Initial Performance and Strategic Market Entry of Liquidia Technologies' Yutrepia Drives Buy RatingValuation and Risks. We reiterate our Buy rating. Our price target of $35 is based on an equally weighted composite of: (a) $35.84/share, as a 20x multiple of taxed and diluted 2035E EPS of $5.57 discounted back to and (b) an NPV discounted cash flow between 2025-2035E of $35.09/share with a discount rate of 12% and growth rate of 2%. These assumptions are in line with an early commercial-stage biopharmaceutical company.
Raymond James
$33→$41
Buy
57.15%
Upside
Reiterated
08/13/25
Wells Fargo
$25→$31
Buy
18.82%
Upside
Reiterated
08/13/25
TR | OpenAI - 4o
$20→$25
Hold
-4.18%
Downside
Reiterated
08/13/25
LifeSci Capital
$41→$54
Buy
106.98%
Upside
Reiterated
08/12/25
Needham
$32→$36
Buy
37.98%
Upside
Reiterated
08/12/25
Bank of America Securities
$23→$35
Buy
34.15%
Upside
Reiterated
08/12/25
Oppenheimer
$6
Sell
-77.00%
Downside
Reiterated
07/29/25
Scotiabank
$37
Buy
41.82%
Upside
Reiterated
06/11/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
$43
Buy
64.81%
Upside
Initiated
08/15/25
Promising Growth and Market Differentiation for Liquidia Technologies: Buy Rating with $43 Price TargetSetup - Assume at Buy, PT $43: *Slides Attached* There are 2 overhangs to LQDA's stock - UTHR patent litigation & INSM's QD TPIP. But at $2.2B mkt cap, we see upside 1) We expect Yutrepia to beat FY'25 (we est. $108M vs $48M cons) & co hits profitability Q4'25, 2) highly unlikely Yutrepia is pulled off mkt from litigation ('327 decision Sep/Aug), 3) oppty for next-gen BID L606 to differentiate vs TPIP (OL data at R&D Day this fall). We model PS $880M for Yutrepia & $491M for L606 (55% POS). Buy, PT $43. ** For our full report, please see the attached ~90-slide deck ** We're assuming coverage of Liquidia Corporation (LQDA) with a Buy rating and PT of $43.
BTIG
$40→$49
Buy
87.81%
Upside
Reiterated
08/13/25
H.C. Wainwright
$35
Buy
34.15%
Upside
Reiterated
08/13/25
Strong Initial Performance and Strategic Market Entry of Liquidia Technologies' Yutrepia Drives Buy RatingValuation and Risks. We reiterate our Buy rating. Our price target of $35 is based on an equally weighted composite of: (a) $35.84/share, as a 20x multiple of taxed and diluted 2035E EPS of $5.57 discounted back to and (b) an NPV discounted cash flow between 2025-2035E of $35.09/share with a discount rate of 12% and growth rate of 2%. These assumptions are in line with an early commercial-stage biopharmaceutical company.
Raymond James
$33→$41
Buy
57.15%
Upside
Reiterated
08/13/25
Wells Fargo
$25→$31
Buy
18.82%
Upside
Reiterated
08/13/25
TR | OpenAI - 4o
$20→$25
Hold
-4.18%
Downside
Reiterated
08/13/25
LifeSci Capital
$41→$54
Buy
106.98%
Upside
Reiterated
08/12/25
Needham
$32→$36
Buy
37.98%
Upside
Reiterated
08/12/25
Bank of America Securities
$23→$35
Buy
34.15%
Upside
Reiterated
08/12/25
Oppenheimer
$6
Sell
-77.00%
Downside
Reiterated
07/29/25
Scotiabank
$37
Buy
41.82%
Upside
Reiterated
06/11/25
Best Analysts Covering Liquidia Technologies
1 Month
xxx
Success Rate
10/15 ratings generated profit
Average Return
+3.80%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +3.80% per trade.
3 Months
xxx
Success Rate
10/15 ratings generated profit
Average Return
+18.01%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +18.01% per trade.
1 Year
Success Rate
15/15 ratings generated profit
Average Return
+72.01%
reiterated a buy rating 2 months ago
Copying Greg Harrison's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +72.01% per trade.
2 Years
xxx
Success Rate
25/25 ratings generated profit
Average Return
+114.21%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +114.21% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LQDA Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
15
39
45
42
21
Buy
2
4
2
3
5
Hold
6
12
13
15
10
Sell
0
1
1
1
0
Strong Sell
0
0
0
1
1
total
23
56
61
62
37
Each month's total comprises the sum of three months' worth of ratings.
LQDA Financial Forecast
LQDA Stock Forecast FAQ
What is LQDA’s average 12-month price target, according to analysts?
Based on analyst ratings, Liquidia Technologies Inc’s 12-month average price target is 35.64.
What is LQDA’s upside potential, based on the analysts’ average price target?
Liquidia Technologies Inc has 36.60% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LQDA a Buy, Sell or Hold?
Liquidia Technologies Inc has a consensus rating of Moderate Buy which is based on 9 buy ratings, 1 hold ratings and 1 sell ratings.
What is Liquidia Technologies Inc’s price target?
The average price target for Liquidia Technologies Inc is 35.64. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $54.00 ,the lowest forecast is $6.00. The average price target represents 36.60% Increase from the current price of $26.09.
The highest analyst price target is $54.00 ,the lowest forecast is $6.00. The average price target represents 36.60% Increase from the current price of $26.09.
What do analysts say about Liquidia Technologies Inc?
Liquidia Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of LQDA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.